Sayda Elbashir
Distinguished Pioneer, Director of Research and Innovation at Moderna @Moderna
Signup · Get unlimited contacts
WORK HISTORY
Distinguished Pioneer, Director of Research and Innovation at Moderna @Moderna
EDUCATION
MAX PLANCK INSTITUTE , Goettingen, Germany
Post-Doc.,, Combinatorial Biochemistry, Molecular/Cellular Biology
GEORG AUGUST UNIVERSITY, Goettingen, Germany
Ph.D, Microbiology/Vaccine Development
GEORG AUGUST UNIVERSITY, Goettingen, Germany
M.SC, Physiology/Animal health
ROYAL VETERINARY UNIVERSITY, Copenhagen, Denmark
D.P.V.M.,, Preventative Vet. Medicine
ABOUT SAYDA ELBASHIR
Innovative principal scientist and key investigator with leadership and diverse, multidisciplinary biomedical research experience including molecular and cellular biology, development of novel cell based assays and techniques for biomedical research, automated high throughput screening, biochemistry, RNAi technology, target validation, drug discovery/development, translation biology, veterinary medicine, pharmacology, immunology, microbiology and key author for more than 25 peer-reviewed articles and patents. Major accomplishments are; Seminal research contributions in the discovery of a novel RNAi tool and the development of a novel method to silence mammalian genes which considered as revolution in research and breakthrough in the science, the outstanding research efforts in evaluating suppression of gene expression of more than 30 genes involve in different pathways and have different functions, the leadership and key role in the drug discovery and development of therapeutic programs, from early discovery through clinical development, the key collaborations with big pharmaceutical companies and academic labs and the substantial scientific and technical impact through professional publications in leading international journal.Specialties: Broad background in biological sciences specialized in biotechnology and bio-pharmaceutics including; RNAi technology, functional genomics, target validation, drug discovery, assay development, in vivo efficacy, PK/PD. Disease areas of my expertise and interest are oncology, metabolic inflammatory and infectious.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.